Document:

Amendment 19 to Contract with FirstGuard Health Plan Kansas, Inc.

 Exhibit 10.3 
  

					
	ROBERT M. DAY, Ph.D, Director	  	

	  	KATHLEEN SEBELIUS, GOVERNOR
		  	DIVISION OF HEALTH POLICY AND FINANCE	  	

 June 8, 2006 
 Jean Rumbaugh 
 FirstGuard Health Plan Kansas, Inc. 
 3801 Blue Parkway 
 Kansas City, MO 64130 
  

	RE:	Amendment Nineteen – Contract #02510 

 Dear Ms. Rumbaugh:

 Enclosed for your files is a fully executed copy of Amendment Nineteen between the Division of Policy and Finance (DHPF) and FirstGuard Health Plan
Kansas, Inc. Thank you for your assistance in getting this contract completed in a timely manner. 
 Should you have questions, don’t hesitate to
contact me at 785-296-8623, or by e-mail at jwxd@srskansas.org. 
  

	
	Sincerely,
	
	/s/ John Dixon
	 John Dixon
 Contract Manager

 JD/ms 
 Enclosure (1) 
 pc: DHPF central file 
 Landon State Office Building, 900 SW Jackson, Room 900N, Topeka, KS 66612 
 Phone 785-296-3981    Fax 785-296-4813 

			
	STATE OF KANSAS	  	Contract No. 02510
	Social and Rehabilitation Services	  	
	Health Care Policy/Medicaid	  	

 AMENDMENT NINETEEN 
 to the 
 KANSAS HEALTHWAVE TITLE XIX AND TITLE XXI CAPITATED MANAGED CARE

 HEALTH SERVICES CONTRACT 
 with 
 FIRSTGUARD HEALTH PLAN KANSAS, INC. 
 2007 SIX MONTH EXTENSION 
 The above referenced agreement, as amended, entered into by and between the Secretary of
Social and Rehabilitation Services, hereinafter referred to as SRS, and FirstGuard Health Plan Kansas, Inc., a Kansas Corporation, hereinafter referred to as FG, on July 12, 2001, and transferred effective July 1, 2005 to the Director of
Health Policy and Finance, hereinafter referred to as DHPF, is hereby amended by agreement of the parties. 
 The Kansas Legislature, in the 2005 Session,
enacted House Substitute for Senate Bill No. 272. This Act establishes the Health Policy Authority (HPA) and also establishes the Division of Health Policy and Finance (DHPF) within the Kansas Department of Administration, effective
July 1, 2005. This Act further provides that the DHPF shall be the single state agency for Medicaid on an interim basis and transfers related responsibilities, duties and contracts, including this contract, from SRS to the new DHPF on
July 1, 2005 and then subsequently provides that the HPA shall be the single state agency for Medicaid effective July 1, 2006 and transfers these same responsibilities, duties and contracts to the HPA on July 1, 2006. 
 DHPF has determined it is in the best interests of the State to make certain changes to the contract as originally agreed upon; and FGK is agreeable to such changes; now
for and in consideration of the mutual covenants and agreements contained herein, the parties hereby mutually covenant and agree as follows: 
 The following documents are referenced for convenience only and are NOT made a part of this 
 amendment or intended to be
incorporated in this contract by this reference. 
 Related Contract Amendment Number/Name: #1; #15, #17, #18 
 Related Memorandum of Understanding Number/Name: N/A 
 Related Policy Number/Name: N/A 
 Related Request For Proposals Reference(s): RFP #02510

 Total Estimated Cost: Title XIX $72,000,000 Title XXI $32,000,000 
  

 Contract #02510, Amendment 19, Page 1 of 3 Pages 

	1.	TERM: 

 By mutual agreement of the parties, the term
of this contract is extended for an additional six months, for the period July 1, 2006 through December 31, 2006. 
  

	2.	MEDICAID TITLE XIX CAPITATION RATES: 

 RFP #02510,
Page 114, Paragraph 5.15.1.e. as amended by Amendment 1 and Amendment 18: 
 The parties agree that for the period March 1, 2006 through
June 30, 2006, the capitation rates set forth in Attachment 1 –Rates for the Period March 1, 2006 through June 30, 2006, attached to and incorporated herein shall apply to Title XIX, subject to actuarial certification and
approval by the Center for Medicare and Medicaid Services (CMS). 
 Is, effective with the signing of this amendment, amended to read:

 The parties agree that for the period July 1, 2006 through December 31, 2006, the capitation rates set forth in Attachment
A – HW XIX Rates for the Period July 1, 2006 through December 31, 2006, attached to and incorporated herein shall apply to HealthWave Title XIX, subject to actuarial certification and approval by the Center for Medicare and
Medicaid Services (CMS). 
  

	3.	SCHIP TITLE XXI CAPITATION RATES FOR THE PERIOD BEGINNING JULY 1, 2006: 

 The parties agree that for the period July 1, 2006 through December 31, 2006, the capitation rates set forth in Attachment B – HealthWave Title XXI Rates for the period July 1, 2006 through
December 31, 2006, attached to and incorporated herein shall apply to HealthWave Title XXI. 
  

	4.	OTHER TERMS AND CONDITIONS: 

 All other terms and
conditions of the contract between SRS and FGK remain unchanged. 
  

 Contract #02510, Amendment 19, Page 2 of 3 Pages 

 IN WITNESS HEREOF, the Parties hereto have executed this amendment to the original contract as of the date written
below. 
  

					
	FIRSTGUARD HEALTH PLAN KANSAS, INC.	 		 	DIVISION OF HEALTH POLICY AND FINANCE
			
	/s/ Jean Rumbaugh	 		 	/s/ Robert M. Day
	Jean Rumbaugh	 		 	Robert M. Day, Ph.D.
	President & COO	 		 	Director
			
	5-4-06	 		 	5-30-2006
	Date	 		 	Date
			
	DEPARTMENT OF ADMINISTRATION DIVISION OF PURCHASES	 		 	
			
	/s/ Chris Howe	 		 	 
	 Chris Howe, Director
 Division of
Purchases
	 		 	
			
	June 05, 2006	 		 	 
	Date	 		 	

  

 Contract #02510, Amendment 19, Page 3 of 3 Pages 

 Attachment A 
 HW XIX Rates Effective July 1, 2006 - December 31, 2006 
 SFY2007 Rates, HealthWave XIX (adjusted for
provider assessment - physician rate increases) 
  

													
	 	  	Johnson,
Leavenworth, &
Wyandotte
Counties	  	Northeast &
Western
Kansas	  	Southeast
Kansas	  	Sedgwick
County
	 TAF & PLE < 1
	  	$	501.76	  	$	508.68	  	$	496.20	  	$	575.18
	 TAF & PLE 1-5
	  	$	97.77	  	$	107.68	  	$	113.72	  	$	86.68
	 TAF & PLE 6-14
	  	$	78.68	  	$	96.38	  	$	99.54	  	$	76.45
	 TAF & PLE 15-21 F
	  	$	151.49	  	$	166.56	  	$	193.03	  	$	166.99
	 TAF & PLE 15-21 M
	  	$	88.11	  	$	112.24	  	$	108.29	  	$	83.86
	 TAF 22-29 F
	  	$	252.61	  	$	246.57	  	$	256.87	  	$	246.93
	 TAF 22-34 M
	  	$	199.17	  	$	199.10	  	$	198.15	  	$	168.76
	 TAF 30-34 F
	  	$	284.11	  	$	301.21	  	$	312.35	  	$	292.20
	 TAF 35+
	  	$	389.40	  	$	459.51	  	$	514.38	  	$	442.20
	 Preg Wom < 30
	  	$	315.48	  	$	293.75	  	$	341.83	  	$	319.94
	 Preg Wom 30+
	  	$	389.19	  	$	368.33	  	$	396.85	  	$	394.71
					
	 Delivery Payment
	  	$	4,987	  			  			  		

 Attachment B 
 HealthWave XXI Rates - Effective July 1, 2006 - December 31, 2006 
  

													
	 	  	JOLVWY	  	NEWE	  	SE	  	SG
	 Up to age 1 Male
	  	$	566.27	  	$	546.27	  	$	465.39	  	$	487.32
	 Up to age 1 Female
	  	$	566.27	  	$	546.27	  	$	465.39	  	$	487.32
	 1 through 5 Male
	  	$	146.74	  	$	117.49	  	$	104.81	  	$	104.81
	 1 through 5 Female
	  	$	143.43	  	$	114.85	  	$	102.45	  	$	102.45
	 6 through 14 Male
	  	$	107.30	  	$	85.92	  	$	76.64	  	$	76.64
	 6 through 14 Female
	  	$	114.64	  	$	91.79	  	$	81.88	  	$	81.88
	 15 through 19 Male
	  	$	138.31	  	$	110.74	  	$	98.79	  	$	98.79
	 15 through 19 Female
	  	$	260.71	  	$	208.74	  	$	186.22	  	$	186.22
	 Pregnant women to age 19
	  	$	1,042.84	  	$	834.99	  	$	744.89	  	$	744.89Form of PIPE Warrant to Purchase Shares of Common Stock

 Exhibit 4.5 
 NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE
SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THESE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES. 
 FLOW INTERNATIONAL CORPORATION 
 WARRANT 
  

			
	Warrant No. [    ]	  	Original Issue Date: [    ], 2005

 Flow International Corporation, a Washington corporation (the “Company”),
hereby certifies that, for value received, [            ] or its registered assigns (the “Holder”), is entitled to purchase from the Company up to a total of
[            ] shares of Common Stock (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”), at any time and from time to time
from and after the Original Issue Date and through and including [            ], 2010 (the “Expiration Date”), and subject to the following terms and conditions:

 1. Definitions. As used in this Warrant, the following terms shall have the respective definitions set forth in this Section 1.
Capitalized terms that are used and not defined in this Warrant that are defined in the Purchase Agreement (as defined below) shall have the respective definitions set forth in the Purchase Agreement. 
 “Business Day” means any day except Saturday, Sunday and any day that is a federal legal holiday in the United States or a day on which
banking institutions in the State of New York are authorized or required by law or other government action to close. 
 “Closing
Price” means, for any date of determination, the price determined by the first of the following clauses that applies: (i) if the Common Stock is then listed or quoted on a Trading Market, the closing bid price per share of the Common
Stock for such date (or the 

 
nearest preceding date) on such market; (ii) if prices for the Common Stock are then quoted on the OTC Bulletin Board, the closing bid price per share
of the Common Stock for such date (or the nearest preceding date) so quoted; (iii) if prices for the Common Stock are then reported in the “Pink Sheets” published by the National Quotation Bureau Incorporated (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported; or (iv) in all other cases, the fair market value of a share of Common Stock as determined by an
independent qualified appraiser selected in good faith and paid for by the Company. 
 “Common Stock” means the common stock
of the Company, par value $.01 per share, and any securities into which such common stock may hereafter be reclassified. 
 “Exercise
Price” means [$  ] 1, subject to adjustment in accordance with Section 9. 
 “Fundamental
Transaction” means any of the following: (i) the Company effects any merger or consolidation of the Company with or into another Person, (ii) the Company effects any sale of all or substantially all of its assets in one or a
series of related transactions, (iii) any tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to tender or exchange their shares for other securities,
cash or property, or (iv) the Company effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property.

 “Original Issue Date” means the Original Issue Date first set forth on the first page of this Warrant. 
 “New York Courts” means the state and federal courts sitting in the City of New York, Borough of Manhattan. 
 “Purchase Agreement” means the Securities Purchase Agreement, dated February [    ], 2005, to which the Company and
the original Holder are parties. 
 “Trading Day” means (i) a day on which the Common Stock is traded on a Trading
Market (other than the OTC Bulletin Board), or (ii) if the Common Stock is not listed on a Trading Market (other than the OTC Bulletin Board), a day on which the Common Stock is traded in the over-the-counter market, as reported by the OTC
Bulletin Board, or (iii) if the Common Stock is not quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as reported by the National Quotation Bureau Incorporated (or any similar organization or
agency succeeding to its functions of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set forth in (i), (ii) and (iii) hereof, then Trading Day shall mean a Business Day. 
  

	1	110% of the Closing Price of the Common Stock on the Trading Day immediately preceding the date that the Purchase Agreement is executed. 

  

 2 

 “Trading Market” means whichever of the New York Stock Exchange, the American Stock
Exchange, the NASDAQ National Market, the NASDAQ SmallCap Market on which the Common Stock is listed or quoted for trading on the date in question. 
 “Warrant Equity Conditions Are Satisfied” means, as of any date of determination, that each of the following conditions is (or would be) satisfied on such date, if the Company were to issue on such date all of the Warrant
Shares then issuable upon exercise in full of all the Warrants: (i) the number of authorized but unissued and otherwise unreserved shares of Common Stock is sufficient for such issuance, (ii) the Common Stock is listed or quoted (and is
not suspended from trading) on a Trading Market and such shares of Common Stock are approved for listing on such market upon issuance, (iii) such Common Stock is registered for resale under the Registration Statement and the prospectus under
such Registration Statement is available for the sale of all Registrable Securities held by the Holder, and (iv) such issuance would be permitted in full without violating Section 11 or the rules or regulations of the Trading Market on
which the Common Stock is then listed or quoted for trading. 
 2. Registration of Warrant. The Company shall register this Warrant
upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute
owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary. 
 3. Registration of Transfers. The Company shall register the transfer of any portion of this Warrant in the Warrant Register, upon surrender of this Warrant, with the Form of Assignment attached hereto duly
completed and signed, to the Company at its address specified herein. Upon any such registration or transfer, a new Warrant to purchase Common Stock, in substantially the form of this Warrant (any such new Warrant, a “New Warrant”),
evidencing the portion of this Warrant so transferred shall be issued to the transferee and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Holder. The acceptance of the
New Warrant by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and obligations of a holder of a Warrant. 
 4. Exercise and Duration of Warrants. 
 (a) This Warrant shall be exercisable by the registered Holder
at any time and from time to time from and after the six month anniversary of the Original Issue Date and through and including the Expiration Date. At 6:30 p.m., New York City time on the Expiration Date, the portion of this Warrant not exercised
prior thereto shall be and become void and of no value. Except as set forth in subsection (b) hereof, the Company may not call or redeem any portion of this Warrant without the prior written consent of the affected Holder. 
 (b) Subject to the provisions of this Section 4(b), commencing the six month anniversary of the Original Issue Date, the Company may deliver a
written notice (such notice, a “Company Exercise Notice”) to the Holder, stating its irrevocable election to cause the exercise at the Exercise Price of all (but not less than all) of this Warrant if each of the following conditions
are satisfied from the date of the Company Exercise Notice through the Company 

  

 3 

 
Exercise Date (as defined below): (i) the Closing Price of the Common Stock for each of the 20 consecutive Trading Days prior to such Company Exercise
Notice exceeds 200% of the Exercise Price then in effect and (ii) the Warrant Equity Conditions Are Satisfied. Subject to the terms and conditions of this Section 4(b), the Company shall effect the exercise of this Warrant pursuant to a
Company Exercise Notice on the 5th Trading Day immediately succeeding the date of the Company Exercise Notice (such
fifth day, the “Company Exercise Date”). Notwithstanding anything to the contrary set forth in this Warrant, the Holder shall have the right to nullify a Company Exercise Notice if any of the conditions set forth in this
Section 4(b) shall not have been met on each date from the date of the Company Exercise Notice through the Company Exercise Date. The parties agree that all exercises of this Warrant that occur on the Company Exercise Date will occur on a
cashless exercise basis. The Company covenants to honor all Exercise Notices delivered prior to the Company Exercise Date. Notwithstanding the foregoing, the Company and the Holder agree that, if and to the extent Section 11 of this Warrant
would restrict the right of the Company to issue or the right of the Holder to receive any of the Warrant Shares otherwise issuable upon the conversion in respect of a Company Exercise Notice, then notwithstanding anything to the contrary set forth
in the Company Exercise Notice, the Company Exercise Notice shall be deemed automatically amended to apply only to such portion of this Warrant as would permit exercise in full in compliance with Section 11. The Holder will promptly (and, in
any event, prior to the Company Exercise Date) notify the Company in writing following receipt of a Company Exercise Notice if Section 11 would restrict its right to receive the full number of otherwise issuable Warrant Shares following such
Company Exercise Notice. 
 5. Delivery of Warrant Shares. 
 (a) To effect exercises hereunder, the Holder shall not be required to physically surrender this Warrant unless the aggregate Warrant Shares represented
by this Warrant is being exercised. Upon (x) delivery of the Exercise Notice (in the form attached hereto) to the Company (with the attached Warrant Shares Exercise Log) at its address for notice set forth herein and upon payment of the
Exercise Price multiplied by the number of Warrant Shares that the Holder intends to purchase hereunder and (y) the Company Exercise Date, the Company shall promptly (but in no event later than three Trading Days after the Date of Exercise (as
defined herein)) issue and deliver to the Holder, a certificate for the Warrant Shares issuable upon such exercise, which, unless otherwise required by the Purchase Agreement, shall be free of restrictive legends. The Company shall, upon request of
the Holder and subsequent to the date on which a registration statement covering the resale of the Warrant Shares has been declared effective by the Securities and Exchange Commission, use its reasonable best efforts to deliver Warrant Shares
hereunder electronically through the Depository Trust Corporation or another established clearing corporation performing similar functions, if available, provided, that, the Company may, but will not be required to change its transfer agent
if its current transfer agent cannot deliver Warrant Shares electronically through the Depository Trust Corporation. A “Date of Exercise” means each of the (A) Company Exercise Date and (B) the date on which the Holder
shall have delivered to the Company: (i) the Exercise Notice (with the Warrant Exercise Log attached to it), appropriately completed and duly signed and (ii) if such Holder is not utilizing the cashless exercise provisions set forth in
this Warrant, payment of the Exercise Price for the number of Warrant Shares so indicated by the Holder to be purchased. 
  

 4 

 (b) If by the third Trading Day after a Date of Exercise the Company fails to deliver the required number
of Warrant Shares in the manner required pursuant to Section 5(a), then the Holder will have the right to rescind such exercise. 
 (c)
If by the third Trading Day after a Date of Exercise the Company fails to deliver the required number of Warrant Shares in the manner required pursuant to Section 5(a), and if after such third Trading Day and prior to the receipt of such
Warrant Shares, the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a
“Buy-In”), then the Company shall (1) pay in cash to the Holder the amount by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (A) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue by (B) the closing bid price of the Common Stock at the time of
the obligation giving rise to such purchase obligation and (2) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored or deliver to the Holder the
number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in
respect of the Buy-In. 
 (d) The Company’s obligations to issue and deliver Warrant Shares in accordance with the terms hereof are
absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or
any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Company or any violation or alleged violation of law by the Holder or any other Person, and
irrespective of any other circumstance which might otherwise limit such obligation of the Company to the Holder in connection with the issuance of Warrant Shares. Nothing herein shall limit a Holder’s right to pursue any other remedies
available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver certificates representing Warrant Shares upon
exercise of the Warrant as required pursuant to the terms hereof. 
 6. Charges, Taxes and Expenses. Issuance and delivery of Warrant
Shares upon exercise of this Warrant shall be made without charge to the Holder for any issue or transfer tax, withholding tax, transfer agent fee or other incidental tax or expense in respect of the issuance of such certificates, all of which taxes
and expenses shall be paid by the Company; provided, however, that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the registration of any certificates for Warrant Shares or Warrants in a
name other than that of the Holder. The Holder shall be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise hereof. 
 7. Replacement of Warrant. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and
substitution for and upon 

  

 5 

 
cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon receipt of evidence reasonably satisfactory to the Company
of such loss, theft or destruction and customary and reasonable indemnity (which shall not include a surety bond), if requested. Applicants for a New Warrant under such circumstances shall also comply with such other reasonable regulations and
procedures and pay such other reasonable third-party costs as the Company may prescribe. If a New Warrant is requested as a result of a mutilation of this Warrant, then the Holder shall deliver such mutilated Warrant to the Company as a condition
precedent to the Company’s obligation to issue the New Warrant. 
 8. Reservation of Warrant Shares. The Company covenants that
it will at all times reserve and keep available out of the aggregate of its authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue Warrant Shares upon exercise of this Warrant as herein
provided, the number of Warrant Shares which are then issuable and deliverable upon the exercise of this entire Warrant, free from preemptive rights or any other contingent purchase rights of Persons other than the Holder (taking into account the
adjustments and restrictions of Section 9). The Company covenants that all Warrant Shares so issuable and deliverable shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof, be duly and
validly authorized, issued and fully paid and nonassessable. 
 9. Certain Adjustments. The Exercise Price and number of Warrant
Shares issuable upon exercise of this Warrant are subject to adjustment from time to time as set forth in this Section 9. 
 (a)
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding, (i) pays a stock dividend on its Common Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common
Stock, (ii) subdivides outstanding shares of Common Stock into a larger number of shares, or (iii) combines outstanding shares of Common Stock into a smaller number of shares, then in each such case the Exercise Price shall be multiplied
by a fraction of which the numerator shall be the number of shares of Common Stock outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any
adjustment made pursuant to clause (i) of this paragraph shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution, and any adjustment pursuant to clause
(ii) or (iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination. 
 (b) Fundamental Transactions. If, at any time while this Warrant is outstanding there is a Fundamental Transaction, then the Holder shall have the right thereafter to receive, upon exercise of this Warrant, the same amount and kind
of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the holder of the number of Warrant Shares then issuable
upon exercise in full of this Warrant (the “Alternate Consideration”). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the
amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate 

  

 6 

 
Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are
given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. At the Holder’s option and request, any successor to the Company or surviving entity in such Fundamental Transaction shall, either (1) issue to the Holder a new warrant substantially in the form of this Warrant and
consistent with the foregoing provisions and evidencing the Holder’s right to purchase the Alternate Consideration for the aggregate Exercise Price upon exercise thereof, or (2) purchase the Warrant from the Holder for a purchase price,
payable in cash within five Trading Days after such request (or, if later, on the effective date of the Fundamental Transaction), equal to the Black Scholes value of the remaining unexercised portion of this Warrant on the date of such request. The
terms of any agreement pursuant to which a Fundamental Transaction is effected shall include terms requiring any such successor or surviving entity to comply with the provisions of this paragraph (b) and insuring that the Warrant (or any such
replacement security) will be similarly adjusted upon any subsequent transaction analogous to a Fundamental Transaction. 
 (c) Number of
Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to this Section 9, the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that
after such adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment. 
 (d) Calculations. All calculations under this Section 9 shall be made to the nearest cent or the nearest 1/100th of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned
or held by or for the account of the Company, and the disposition of any such shares shall be considered an issue or sale of Common Stock. 
 (e) Notice of Adjustments. Upon the occurrence of each adjustment pursuant to this Section 9, the Company at its expense will promptly compute such adjustment in accordance with the terms of this Warrant and prepare a
certificate setting forth such adjustment, including a statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions
giving rise to such adjustments and showing in detail the facts upon which such adjustment is based. Upon written request, the Company will promptly deliver a copy of each such certificate to the Holder and to the Company’s Transfer Agent.

 (f) Notice of Corporate Events. If the Company (i) declares a dividend or any other distribution of cash, securities or other
property in respect of its Common Stock, including without limitation any granting of rights or warrants to subscribe for or purchase any capital stock of the Company or any Subsidiary, (ii) authorizes or approves, enters into any agreement
contemplating or solicits stockholder approval for any Fundamental Transaction or (iii) authorizes the voluntary dissolution, liquidation or winding up of the affairs of the Company, then the Company shall deliver to the Holder a notice
describing the material terms and 

  

 7 

 
conditions of such transaction (but only to the extent such disclosure would not result in the dissemination of material, non-public information to the
Holder) at least 10 calendar days prior to the applicable record or effective date on which a Person would need to hold Common Stock in order to participate in or vote with respect to such transaction, and the Company will take all steps reasonably
necessary in order to insure that the Holder is given the practical opportunity to exercise this Warrant prior to such time so as to participate in or vote with respect to such transaction; provided, however, that the failure to deliver such notice
or any defect therein shall not affect the validity of the corporate action required to be described in such notice. 
 10. Payment of
Exercise Price. The Holder may pay the Exercise Price in one of the following manners: 
 (a) Cash Exercise. The Holder may deliver
immediately available funds; or 
 (b) Cashless Exercise. If an Exercise Notice is delivered at a time when a registration statement
permitting the Holder to resell the Warrant Shares is not then effective or the prospectus forming a part thereof is not then available to the Holder for the resale of the Warrant Shares, then the Holder may notify the Company in an Exercise Notice
of its election to utilize cashless exercise, in which event the Company shall issue to the Holder the number of Warrant Shares determined as follows: 
  

					
		 		 	X = Y [(A-B)/A]
			
		 	where:	 	
			
		 		 	X = the number of Warrant Shares to be issued to the Holder.
			
		 		 	Y = the number of Warrant Shares with respect to which this Warrant is being exercised.
			
		 		 	A = the average of the closing prices for the five Trading Days immediately prior to (but not including) the Exercise Date.
			
		 		 	B = the Exercise Price.

 For purposes of Rule 144 promulgated under the Securities Act, it is intended, understood and acknowledged that
the Warrant Shares issued in a cashless exercise transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.

 11. Limitations on Exercise. Notwithstanding anything to the contrary contained herein, the number of Warrant Shares that may be
acquired by the Holder upon any exercise of this Warrant (or otherwise in respect hereof) shall be limited to the extent necessary to insure that, following such exercise (or other issuance), the total number of shares of Common Stock then
beneficially owned by such Holder and its Affiliates and any other Persons whose beneficial ownership of Common Stock would be aggregated with the Holder’s for purposes of Section 13(d) of the Exchange Act, does not exceed 9.999% of the
total number of issued and outstanding shares of Common Stock (including for such purpose the shares of Common Stock 

  

 8 

 
issuable upon such exercise). For such purposes, beneficial ownership shall be determined in accordance with Section 13(d) of the Exchange Act and the
rules and regulations promulgated thereunder. This provision shall not restrict the number of shares of Common Stock which a Holder may receive or beneficially own in order to determine the amount of securities or other consideration that such
Holder may receive in the event of a Fundamental Transaction as contemplated in Section 9 of this Warrant. This restriction may not be waived. 
 12. No Fractional Shares. No fractional shares of Warrant Shares will be issued in connection with any exercise of this Warrant. In lieu of any fractional shares which would, otherwise be issuable, the Company shall pay cash equal to
the product of such fraction multiplied by the closing price of one Warrant Share as reported by the applicable Trading Market on the date of exercise. 
 13. Notices. Any and all notices or other communications or deliveries hereunder (including, without limitation, any Exercise Notice) shall be in writing and shall be deemed given and effective on the earliest
of (i) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number specified in this Section prior to 6:30 p.m. (New York City time) on a Trading Day, (ii) the next Trading Day after the
date of transmission, if such notice or communication is delivered via facsimile at the facsimile number specified in this Section on a day that is not a Trading Day or later than 6:30 p.m. (New York City time) on any Trading Day, (iii) the
Trading Day following the date of mailing, if sent by nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. The addresses for such communications shall be:
(i) if to the Company, to Flow International Corporation, Attn: President, or to Facsimile No.: (253) 813-3285 (or such other address as the Company shall indicate in writing in accordance with this Section), or (ii) if to the Holder,
to the address or facsimile number appearing on the Warrant Register or such other address or facsimile number as the Holder may provide to the Company in accordance with this Section. 
 14. Warrant Agent. The Company shall serve as warrant agent under this Warrant. Upon 10 days’ notice to the Holder, the Company may appoint a
new warrant agent. Any corporation into which the Company or any new warrant agent may be merged or any corporation resulting from any consolidation to which the Company or any new warrant agent shall be a party or any corporation to which the
Company or any new warrant agent transfers substantially all of its corporate trust or shareholders services business shall be a successor warrant agent under this Warrant without any further act. Any such successor warrant agent shall promptly
cause notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder’s last address as shown on the Warrant Register. 
 15. Miscellaneous. 
 (a) This Warrant
shall be binding on and inure to the benefit of the parties hereto and their respective successors and assigns. Subject to the preceding sentence, nothing in this Warrant shall be construed to give to any Person other than the Company and the Holder
any legal or equitable right, remedy or cause of action under this Warrant. This Warrant may be amended only in writing signed by the Company and the Holder and their successors and assigns. 
  

 9 

 (b) All questions concerning the construction, validity, enforcement and interpretation of this Warrant
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York (except for matters governed by corporate law in the State of Delaware), without regard to the principles of conflicts of law thereof. Each
party agrees that all legal proceedings concerning the interpretations, enforcement and defense of this Warrant and the transactions herein contemplated (“Proceedings”) (whether brought against a party hereto or its respective
Affiliates, employees or agents) shall be commenced exclusively in the New York Courts. Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection
herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any New York Court, or that such
Proceeding has been commenced in an improper or inconvenient forum. Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered or
certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and notice thereof.
Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Each party hereto hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by
jury in any legal proceeding arising out of or relating to this Warrant or the transactions contemplated hereby. If either party shall commence a Proceeding to enforce any provisions of this Warrant, then the prevailing party in such Proceeding
shall be reimbursed by the other party for its attorney’s fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Proceeding. 
 (c) The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any of the
provisions hereof. 
 (d) In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the
validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby and the parties will attempt in good faith to agree upon a valid and enforceable provision which shall be a
commercially reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Warrant. 
 (e) Prior
to exercise of this Warrant, the Holder hereof shall not, by reason of by being a Holder, be entitled to any rights of a stockholder with respect to the Warrant Shares 
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK, 
 SIGNATURE PAGE FOLLOWS] 
  

 10 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its authorized officer as
of the date first indicated above. 
  

			
	FLOW INTERNATIONAL CORPORATION
		
	By:	 	  

	Name:	 	
	Title:	 	

  

 11 

 EXERCISE NOTICE 
 FLOW INTERNATIONAL CORPORATION 
 WARRANT DATED [    ], 2005 
 The undersigned Holder hereby irrevocably elects to purchase
                         shares of Common Stock pursuant to the above referenced Warrant. Capitalized terms used herein
and not otherwise defined have the respective meanings set forth in the Warrant. 
 (1) The undersigned Holder hereby exercises its right to purchase
             Warrant Shares pursuant to the Warrant. 
 (2) The Holder intends that
payment of the Exercise Price shall be made as (check one): 
                         “Cash Exercise” under Section 10 
                         “Cashless Exercise” under Section 10 
 (3) If the holder has elected a Cash Exercise, the holder shall pay the sum of
$                         to the Company in accordance with the terms of the Warrant. 
 (4) Pursuant to this Exercise Notice, the Company shall deliver to the holder
                         Warrant Shares in accordance with the terms of the Warrant. 
 (5) By its delivery of this Exercise Notice, the undersigned represents and warrants to the Company that in giving effect to the exercise evidenced hereby the Holder
will not beneficially own in excess of the number of shares of Common Stock (determined in accordance with Section 13(d) of the Securities Exchange Act of 1934) permitted to be owned under Section 11 of this Warrant to which this notice
relates. 
  

					
	Dated:                         ,
            	 	Name of Holder:
			
		 	(Print)	 	  

			
		 	By:	 	  

		 	Name:	 	  

		 	Title:	 	  

		
		 	(Signature must conform in all respects to name of holder as specified on the face of the Warrant)

  

 12 

 Warrant Shares Exercise Log 
  

							
	 Date
	  	 Number of Warrant
 Shares Available to be
 Exercised
	  	 Number of Warrant Shares
Exercised
	  	 Number of
 Warrant Shares
 Remaining to
 be Exercised

		  		  		  	
		  		  		  	
		  		  		  	

  

 13 

 FLOW INTERNATIONAL CORPORATION 
 WARRANT ORIGINALLY ISSUED [    ], 2005 
 WARRANT NO.
[    ] 
 FORM OF ASSIGNMENT 
 [To be completed and signed only upon transfer of Warrant] 
 FOR VALUE RECEIVED, the undersigned hereby
sells, assigns and transfers unto
                                        
                 the right represented by the above-captioned Warrant to purchase
                         shares of Common Stock to which such Warrant relates and appoints
                         attorney to transfer said right on the books of the Company with full power of substitution in
the premises. 
  

	Dated:	                        ,
             

  

	
	  

	(Signature must conform in all respects to name of holder as specified on the face of the Warrant)
	
	  

	Address of Transferee
	
	  

	
	  

  

	
	In the presence of:
	
	   

  

 14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00107-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00107-of-00352.parquet"}]]